UBIQUITINYLIERTE PROTEINE

European patent · EP3055322 · In force

Register entry

Publication number
EP3055322
Application number
EP14851719
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 10, 2014
Published
Aug 17, 2016
Granted
Sep 25, 2019
Protection ends at the latest
Oct 9, 2034
Next annual fee due
Oct 31, 2026
IPC classes
A61K 39/00 (2006.01)
Priority
US 201361890054 P 11.10.2013
PCT application
PCT/US2014/060180 10.10.2014
PCT publication
WO2015/054668 16.04.2015
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  3. Apr 29, 2024

    Change

    Published in Swissreg on 29.04.2024

  4. Nov 1, 2022

    Change

    Published in Swissreg on 01.11.2022

  5. Sep 25, 2019

    Granted

    Published in Swissreg on 25.09.2019

Parties

Holder

Providence Health & Services - Oregon

1235 NE 47th Avenue, Portland, OR 97213, US

Ubivac, LLC

4805 NE Glisan Street, 5F58, Portland, Oregon 97213, US

Inventor

HU, Hong-Ming

Portland, Oregon 97232, US

LESHANE, Erik

Portland, Oregon 97206, US

YU, Guangjie

Hohhot Nei Mongol, CN

FOX, Bernard

Portland, Oregon 97213, US

TWITTY, Christopher

San Diego, California 92109, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.